Checkmate-067

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Checkmate-067

Mar 29, 2025, 04:55 | Blog

Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:…

Sep 17, 2024, 16:15 | Blog

Median overall survival in melanoma with nivolumab plus ipilimumab presented at ESMO24 - NEJM

NEJM posted the following on X: “Presented at ESMO24: Among patients with advanced melanoma, median…

May 25, 2024, 10:05 | Insight

Marco Donia: The Role of PD-L1 Assessment in Dual Checkpoint Inhibition for Melanoma

Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "The…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023